Medical Weight Loss for Elkhart, Indiana Residents

Elkhart, Indiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Elkhart through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Start this week from Elkhart: book a video visit, complete your intake, and if you are a fit, your compounded medication ships to your Indiana door. No travel to California required. Doctor review just $119 (medication separate).

Why Elkhart Residents Choose New Hope Weight Loss

Some patients in Elkhart are weighing semaglutide against tirzepatide, and that is a conversation worth having with a doctor, not a website. Dr. Anjmun Sharma helps you understand the trade-offs, the cost difference between $166 and $233 a month, and what the trial data actually showed, with semaglutide averaging about 15 to 17 percent body-weight loss and tirzepatide reaching up to 22.5 percent at qualifying doses. These are compounded, not brand-identical, and results vary, so the choice should be informed.

From our Costa Mesa, California practice, we provide Elkhart with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

From the first visit to your refills, people in Elkhart, Indiana are cared for by Dr. Sharma through telehealth, so the only thing missing is the commute to Costa Mesa. We care for patients throughout downtown Elkhart and the greater Elkhart County area of northern Indiana. Wherever you live in Indiana, your medication ships straight to your door in discreet packaging, so the same care reaches you whether you are in Elkhart proper or one of the surrounding downtown Elkhart and the greater Elkhart County area of northern Indiana.

A patient in the busiest part of Elkhart and one in a quiet Indiana suburb pay exactly the same: $119 for the physician review and semaglutide from $166 per month. Your compounded semaglutide or tirzepatide ships directly to your Elkhart address in an insulated cold-pack box, so it stays stable in transit. New Hope Weight Loss treats patients throughout Indiana entirely by telehealth from our Costa Mesa, California clinic, so the same physician care comes to you wherever you live in the state.

GLP-1 Weight Loss Programs Available

Semaglutide: the 90-Day Metabolic Reset

If you live in Elkhart and want a clear starting point, this is it. Semaglutide, the active ingredient also used in Wegovy and Ozempic, costs from $166 per month or $499 for the 90-day program. Branded-drug trials showed roughly 15 to 17 percent average weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, so results vary.

Tirzepatide: the dual GLP-1 and GIP option

For patients who want a second lever, tirzepatide starts at $233 per month and acts on both GLP-1 and GIP receptors. Up to 22.5 percent body-weight loss appeared in branded-drug trials at qualifying doses, which is not typical. It shares an active ingredient with Mounjaro and Zepbound.

A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.

How Telehealth Works for Elkhart

From your first quiz to your last follow-up, the process is built for busy people in Elkhart.

1. Complete a secure online intake about your medical history and weight goals.

2. Dr. Sharma reviews it and meets you over secure video, usually within 48 hours.

3. If a compounded GLP-1 suits you, a state-licensed 503(a) pharmacy ships semaglutide or tirzepatide to your Elkhart home in cold-pack packaging.

4. You continue with video follow-ups, anywhere in , at the cadence your plan calls for.

Frequently Asked Questions, Elkhart

Does New Hope Weight Loss actually serve Elkhart, or only Costa Mesa?

We serve both. Our single physical location sits in Costa Mesa, California, and we extend care to Elkhart, Indiana through telehealth. Residents across neighborhoods like downtown Elkhart and the greater Elkhart County area of northern Indiana qualify the same way. Dr. Anjmun Sharma evaluates whether a compounded GLP-1 plan fits you during your initial video appointment.

Can the whole process be done remotely from Elkhart?

Yes, it is fully remote. There is no in-person requirement for Elkhart patients at any stage. You meet Dr. Sharma over video, complete intake online, and receive ongoing support by message. Approved prescriptions arrive at your door in insulated cold-pack shipping that protects the medication during delivery.

How much will a Elkhart patient pay?

Plan on $119 for the physician visit. Semaglutide runs from $166 monthly, with a $499 option for 90 days, and tirzepatide from $233 monthly. The medication cost is separate from the visit. HSA, FSA, Klarna, and Affirm are all welcome, and Elkhart residents pay no added distance fee.

What areas of Elkhart do you serve?

We serve patients from across Elkhart by telehealth, including downtown Elkhart and the greater Elkhart County area of northern Indiana.

How does telehealth treatment work for Elkhart patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Elkhart address. Follow-ups also happen by video.

Elkhart Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Elkhart, Indiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.